NKCC1 Antibody [A2N20] Datasheet

Biological Description

Specificity	NKCC1 Antibody [A2N20] detects endogenous levels of total NKCC1 protein.
Background	NKCC1 (Na⁺‑K⁺‑2Cl⁻ cotransporter 1, SLC12A2) is a ubiquitously expressed member of the cation–chloride cotransporter family that mediates electroneutral cotransport of Na⁺, K⁺, and Cl⁻ across the plasma membrane and has a central role in intracellular Cl⁻ accumulation, osmotic balance, and cell volume control in neuronal, epithelial, and other mammalian cells. The protein functions as a secondary‑active transporter that uses the inward Na⁺ gradient and the Na⁺/K⁺‑ATPase‑maintained K⁺ gradient to drive the net influx of one Na⁺, one K⁺, and two Cl⁻ ions, and this ion movement contributes to transepithelial NaCl secretion in secretory epithelia and to high intracellular Cl⁻ concentrations in many neurons. NKCC1 belongs to the Na⁺‑dependent branch of the CCC family together with NKCC2 and NCC and is widely distributed in brain, secretory glands, inner ear, vasculature, and other tissues, where it supports fundamental processes such as epithelial Cl⁻ secretion, K⁺ and Cl⁻ homeostasis, regulation of cell size, and control of neuronal excitability. The transporter is characterized by multiple transmembrane helices that form the ion translocation core and by large cytosolic N‑ and C‑terminal domains that contain regulatory phosphorylation sites, motifs for interaction with kinases and phosphatases, and determinants of membrane trafficking and stability, placing NKCC1 under tight control by cell volume and ionic conditions. NKCC1 acts as a basolateral uptake pathway for Na⁺, K⁺, and Cl⁻ in secretory epithelia; this role supports apical Cl⁻ exit through channels and contributes to fluid secretion in airways, intestine, and exocrine glands, and NKCC1 activity is a key determinant of the rate of epithelial secretion in conditions such as secretory diarrhea and airway hypersecretion. In the nervous system, NKCC1 is expressed in neurons and glia and participates in Cl⁻ accumulation in developing and some mature neurons, where its transport activity sets the Cl⁻ equilibrium potential and thereby influences whether GABA_A receptor activation is depolarizing or hyperpolarizing, linking NKCC1 to the control of inhibitory versus excitatory GABA signaling and to neuronal network excitability. NKCC1 is also expressed in astrocytes and contributes to ionic composition and cell volume regulation, including responses to elevated extracellular K⁺ and ischemic conditions, where NKCC1 activity is associated with NaCl influx, water entry, and astrocytic swelling, and the cotransporter is pharmacologically sensitive to loop diuretics such as bumetanide and furosemide. Altered NKCC1 expression or regulation participates in the development of hypertension through effects on vascular smooth muscle and renal salt handling and contributes to edema and neuronal hyperexcitability in cerebral ischemia and several neurological conditions; genetic identification of SLC12A2 variants as causes of human disease confirms NKCC1 as a disease‑causing ion transporter associated with neurodevelopmental, auditory, and multisystem phenotypes.

Specificity

NKCC1 Antibody [A2N20] detects endogenous levels of total NKCC1 protein.

Background

NKCC1 (Na⁺‑K⁺‑2Cl⁻ cotransporter 1, SLC12A2) is a ubiquitously expressed member of the cation–chloride cotransporter family that mediates electroneutral cotransport of Na⁺, K⁺, and Cl⁻ across the plasma membrane and has a central role in intracellular Cl⁻ accumulation, osmotic balance, and cell volume control in neuronal, epithelial, and other mammalian cells. The protein functions as a secondary‑active transporter that uses the inward Na⁺ gradient and the Na⁺/K⁺‑ATPase‑maintained K⁺ gradient to drive the net influx of one Na⁺, one K⁺, and two Cl⁻ ions, and this ion movement contributes to transepithelial NaCl secretion in secretory epithelia and to high intracellular Cl⁻ concentrations in many neurons. NKCC1 belongs to the Na⁺‑dependent branch of the CCC family together with NKCC2 and NCC and is widely distributed in brain, secretory glands, inner ear, vasculature, and other tissues, where it supports fundamental processes such as epithelial Cl⁻ secretion, K⁺ and Cl⁻ homeostasis, regulation of cell size, and control of neuronal excitability. The transporter is characterized by multiple transmembrane helices that form the ion translocation core and by large cytosolic N‑ and C‑terminal domains that contain regulatory phosphorylation sites, motifs for interaction with kinases and phosphatases, and determinants of membrane trafficking and stability, placing NKCC1 under tight control by cell volume and ionic conditions. NKCC1 acts as a basolateral uptake pathway for Na⁺, K⁺, and Cl⁻ in secretory epithelia; this role supports apical Cl⁻ exit through channels and contributes to fluid secretion in airways, intestine, and exocrine glands, and NKCC1 activity is a key determinant of the rate of epithelial secretion in conditions such as secretory diarrhea and airway hypersecretion. In the nervous system, NKCC1 is expressed in neurons and glia and participates in Cl⁻ accumulation in developing and some mature neurons, where its transport activity sets the Cl⁻ equilibrium potential and thereby influences whether GABA_A receptor activation is depolarizing or hyperpolarizing, linking NKCC1 to the control of inhibitory versus excitatory GABA signaling and to neuronal network excitability. NKCC1 is also expressed in astrocytes and contributes to ionic composition and cell volume regulation, including responses to elevated extracellular K⁺ and ischemic conditions, where NKCC1 activity is associated with NaCl influx, water entry, and astrocytic swelling, and the cotransporter is pharmacologically sensitive to loop diuretics such as bumetanide and furosemide. Altered NKCC1 expression or regulation participates in the development of hypertension through effects on vascular smooth muscle and renal salt handling and contributes to edema and neuronal hyperexcitability in cerebral ischemia and several neurological conditions; genetic identification of SLC12A2 variants as causes of human disease confirms NKCC1 as a disease‑causing ion transporter associated with neurodevelopmental, auditory, and multisystem phenotypes.

Usage Information

Application

WB, IP, IHC, IF, FCM

Dilution

WB	IP	IHC	IF	FCM
1:1000	1:30	1:100	1:100	1:150

Reactivity

Human, Mouse, Rat

Source

Rabbit Monoclonal Antibody

MW

131 kDa

Storage Buffer

PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage
(from the date of receipt)

-20°C (avoid freeze-thaw cycles), 2 years

References

https://pubmed.ncbi.nlm.nih.gov/26114157/
https://pubmed.ncbi.nlm.nih.gov/33345190/

NKCC1 Antibody [A2N20]

Biological Description

Usage Information

References

Application Data